Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Lange

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 23, 2019
BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinomaMaria Wiethaler, Julia Slotta-Huspenina, Anna Brandtner, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)David Witte, Ina Pretzell, Timm M Reissig, et al.
Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in miceJulia Weber, Rupert Öllinger, Mathias Friedrich, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Nature Communications|March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasisAnna Lorentzen, Paul F Becker, Jan Kosla, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Gastroenterology|April 24, 2020
Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to AdenocarcinomaBettina Kunze, Frederik Wein, Hsin-Yu Fang, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 23, 2019
BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinomaMaria Wiethaler, Julia Slotta-Huspenina, Anna Brandtner, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)David Witte, Ina Pretzell, Timm M Reissig, et al.
Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in miceJulia Weber, Rupert Öllinger, Mathias Friedrich, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Nature Communications|March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasisAnna Lorentzen, Paul F Becker, Jan Kosla, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Gastroenterology|April 24, 2020
Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to AdenocarcinomaBettina Kunze, Frederik Wein, Hsin-Yu Fang, et al.
Pageof 7